References
- Beutler B, Rietschel ET. (2003). Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3:169–76.
- Bobowski-Gerard M, Zummo FP, Staels B, et al. (2018). Retinoids issued from hepatic stellate cell lipid droplet loss as potential signaling molecules orchestrating a multicellular liver injury response. Cells 7:pii: E137.
- Cardenas A, Restrepo JC, Sierra F, et al. (2006). Acute hepatitis due to shen-min: a herbal product derived from Polygonum multiflorum. J Clin Gastroenterol 40:629–32.
- Chalasani NP, Hayashi PH, Bonkovsky HL, et al. (2014). ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 109:950–66.
- Chen M, Suzuki A, Borlak J, et al. (2015). Drug-induced liver injury: interactions between drug properties and host factors. J Hepatol 63:503–14.
- Gao D, Li Y-m, Wang N, et al. (2016). Establishment and validation of quantitative analysis of multi-components by single marker for quality control of polygoni multiflori radix. Anal Methods 8:7170.
- Ghandforoush-Sattari M, Mashayekhi S. (2008). Evaluation of taurine as a biomarker of liver damage in paracetamol poisoning. Eur J Pharmacol 581:171–6.
- Gomez-Munoz A, Presa N, Gomez-Larrauri A, et al. (2016). Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate. Prog Lipid Res 61:51–62.
- Han L, Wang P, Wang Y, et al. (2019). Rapid discovery of the potential toxic compounds in polygonum multiflorum by UHPLC/Q-Orbitrap-MS-based metabolomics and correlation analysis. Front Pharmacol 10:329.
- Jung KA, Min HJ, Yoo SS, et al. (2011). Drug-Induced liver injury: twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum thunb. Gut Liver 5:493–9.
- Lei X, Chen J, Ren J, et al. (2015). Liver damage associated with Polygonum multiflorum thunb.: a systematic review of case reports and case series. Evid Based Complement Alternat Med 2015:459749.
- Li C, Rao T, Chen X, et al. (2019). HLA-B*35:01 allele is a potential biomarker for predicting Polygonum multiflorum-induced liver injury in humans. Hepatology 70:346–57.
- Li CY, Li XF, Tu C, et al. (2015). The idiosyncratic hepatotoxicity of Polygonum multiflorum based on endotoxin model. Acta Pharm Sin 50:28–33.
- Li CY, Tu C, Gao D, et al. (2016). Metabolomic study on idiosyncratic liver injury induced by different extracts of Polygonum multiflorum in rats integrated with pattern recognition and enriched pathways analysis. Front Pharmacol 7:483.
- Li Y-x, Gong X-h, Liu M-c, et al. (2017). A new strategy for quality evaluation and identification of representative chemical components in Polygonum multiflorum thunb. Evid Based Complement Alternat Med 2017:1–11.
- Liang L, Xu J, Zhou WW, et al. (2018). Integrating targeted and untargeted metabolomics to investigate the processing chemistry of Polygoni Multiflori Radix. Front Pharmacol 9:934.
- Liang Z, Chen H, Yu Z, et al. (2010). Comparison of raw and processed Radix Polygoni Multiflori (Heshouwu) by high performance liquid chromatography and mass spectrometry. Chin Med 5:29.
- Lin L, Ni B, Lin H, et al. (2015). Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review. J Ethnopharmacol 159:158–83.
- Luyendyk JP, Maddox JF, Green CD, et al. (2004). Role of hepatic fibrin in idiosyncrasy-like liver injury from lipopolysaccharide-ranitidine coexposure in rats. Hepatology 40:1342–51.
- Lv GP, Meng LZ, Han DQ, et al. (2015). Effect of sample preparation on components and liver toxicity of Polygonum multiflorum. J Pharm Biomed Anal 109:105–11.
- Maceyka M, Harikumar KB, Milstien S, et al. (2012). Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22:50–60.
- Maceyka M, Spiegel S. (2014). Sphingolipid metabolites in inflammatory disease. Nature 510:58–67.
- Mitchell D, Wagner C, Stone WJ, et al. (1976). Abnormal regulation of plasma pyridoxal 5'-phosphate in patients with liver disease. Gastroenterology 71:1043–9.
- O'Byrne SM, Blaner WS. (2013). Retinol and retinyl esters: biochemistry and physiology. J Lipid Res 54:1731–43.
- Pagadala M, Kasumov T, McCullough AJ, et al. (2012). Role of ceramides in nonalcoholic fatty liver disease. Trends Endocrinol Metab 23:365–71.
- Tu C, Ge FL, Guo YM, et al. (2019a). Analysis of clinical characteristics and medication rationality of Polygonum Multiflorum Thunb. and its preparation-related liver injury. Chin J Pharmacov 16:270–6.
- Tu C, He Q, Li CY, et al. (2019). Susceptibility-related factor and biomarkers of dietary supplement Polygonum multiflorum-induced liver injury in rats. Front Pharmacol 10:335.
- Wang TH, Zhang J, Qiu XH, et al. (2015). Application of ultra-high-performance liquid chromatography coupled with LTQ-orbitrap mass spectrometry for the qualitative and quantitative analysis of Polygonum multiflorum Thumb. and its processed products. Molecules 21:E40.
- Waring JF, Liguori MJ, Luyendyk JP, et al. (2006). Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils. J Pharmacol Exp Ther 316:1080–7.
- Wu X, Chen X, Huang Q, et al. (2012). Toxicity of raw and processed roots of Polygonum multiflorum. Fitoterapia 83:469–75.
- Zhao J, Xie C, Mu X, et al. (2018). Metabolic alterations in triptolide-induced acute hepatotoxicity. Biomed Chromatogr 32:e4299.
- Zhu Y, Liu SH, Wang JB, et al. (2015). Clinical analysis of drug-induced liver injury caused by Polygonum multiflorum and its Preparations. Chin J Integr Tradit West Med 35:1442–7.